210 related articles for article (PubMed ID: 34620213)
1. INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care-study protocol for a multicentre randomised controlled trial.
High J; Enne VI; Barber JA; Brealey D; Turner DA; Horne R; Peters M; Dhesi Z; Wagner AP; Pandolfo AM; Stirling S; Russell C; O'Grady J; Swart AM; Gant V; Livermore DM;
Trials; 2021 Oct; 22(1):680. PubMed ID: 34620213
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
[TBL] [Abstract][Full Text] [Related]
3. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation.
Hellyer TP; McAuley DF; Walsh TS; Anderson N; Conway Morris A; Singh S; Dark P; Roy AI; Perkins GD; McMullan R; Emerson LM; Blackwood B; Wright SE; Kefala K; O'Kane CM; Baudouin SV; Paterson RL; Rostron AJ; Agus A; Bannard-Smith J; Robin NM; Welters ID; Bassford C; Yates B; Spencer C; Laha SK; Hulme J; Bonner S; Linnett V; Sonksen J; Van Den Broeck T; Boschman G; Keenan DJ; Scott J; Allen AJ; Phair G; Parker J; Bowett SA; Simpson AJ
Lancet Respir Med; 2020 Feb; 8(2):182-191. PubMed ID: 31810865
[TBL] [Abstract][Full Text] [Related]
4. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial.
Foucrier A; Roquilly A; Bachelet D; Martin-Loeches I; Bougle A; Timsit JF; Montravers P; Zahar JR; Eloy P; Weiss E;
BMJ Open; 2023 Feb; 13(2):e065293. PubMed ID: 36810173
[TBL] [Abstract][Full Text] [Related]
6. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units.
Chen CL; Tseng HY; Chen WC; Liang SJ; Tu CY; Lin YC; Hsueh PR
J Microbiol Immunol Infect; 2024 Jun; 57(3):480-489. PubMed ID: 38471985
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics for ventilator-associated pneumonia.
Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
[TBL] [Abstract][Full Text] [Related]
8. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study.
Enne VI; Aydin A; Baldan R; Owen DR; Richardson H; Ricciardi F; Russell C; Nomamiukor-Ikeji BO; Swart AM; High J; Colles A; Barber J; Gant V; Livermore DM; O'Grady J;
Thorax; 2022 Dec; 77(12):1220-1228. PubMed ID: 35027473
[TBL] [Abstract][Full Text] [Related]
9. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
10. Continuous versus intermittent endotracheal cuff pressure control for the prevention of ventilator-associated respiratory infections in Vietnam: study protocol for a randomised controlled trial.
Dat VQ; Geskus RB; Wolbers M; Loan HT; Yen LM; Binh NT; Chien LT; Mai NTH; Phu NH; Lan NPH; Hao NV; Long HB; Thuy TP; Kinh NV; Trung NV; Phu VD; Cap NT; Trinh DT; Campbell J; Kestelyn E; Wertheim HFL; Wyncoll D; Thwaites GE; van Doorn HR; Thwaites CL; Nadjm B
Trials; 2018 Apr; 19(1):217. PubMed ID: 29615093
[TBL] [Abstract][Full Text] [Related]
11. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.
Mo Y; Booraphun S; Li AY; Domthong P; Kayastha G; Lau YH; Chetchotisakd P; Limmathurotsakul D; Tambyah PA; Cooper BS;
Lancet Respir Med; 2024 May; 12(5):399-408. PubMed ID: 38272050
[TBL] [Abstract][Full Text] [Related]
12. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
13. Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia.
Wagner AP; Enne VI; Livermore DM; Craig JV; Turner DA;
J Hosp Infect; 2020 Dec; 106(4):745-756. PubMed ID: 32971194
[TBL] [Abstract][Full Text] [Related]
14. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
15. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
18. Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial.
Mo Y; West TE; MacLaren G; Booraphun S; Li AY; Kayastha G; Lau YH; Chew YT; Chetchotisakd P; Tambyah PA; Limmathurotsakul D; Cooper B
BMJ Open; 2021 May; 11(5):e050105. PubMed ID: 33986070
[TBL] [Abstract][Full Text] [Related]
19. Duration of Antibiotic Therapy for Early VAP Trial: Study Protocol for a Surgical Infection Society Multicenter, Pragmatic, Randomized Clinical Trial of Four versus Seven Days of Definitive Antibiotic Therapy for Early Ventilator-Associated Pneumonia in Surgical Patients.
Meizoso JP; Sauaia A; Namias N; Manning RJ; Pieracci FM
Surg Infect (Larchmt); 2023 Mar; 24(2):163-168. PubMed ID: 36730717
[No Abstract] [Full Text] [Related]
20. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
